Incyte | INCY - 利息收入

股票价格

96.95

每天变化

1.06 1.11%

每月一次

0.97%

每年

75.73%

Q2 预测

93.04

金融业

USD

USD 6.96B

现金及等价物

USD 3.58B

USD 121.18M

USD 5.02B

USD 1.52B

USD 40.41M

USD 383.88M

USD 414.51M

2.62K

EPS每股收益

USD 1.8

股本和储备

USD 5.17B

USD 1.39B

债务利息支出

USD 582K

USD 30.75M

USD 30.2M

USD 21.48B

USD 299.28M

USD 1.12B

USD 383.88M

普通股股本

USD 198.46M

14.84

USD 389.94M

USD 1.51B

销售和管理费用

USD 390.41M

USD 101.06M

贸易债权人

USD 1.63B

应收帐款人

USD 1.02B

	利息收入	更改		日
Acadia Pharmaceuticals	USD 8.25M		1M	2025-09
Agios Pharmaceuticals	USD 13.37M		1.14M	2025-09
Alnylam Pharmaceuticals	USD 28.68M		1.19M	2025-09
BioCryst Pharmaceuticals	USD -0.13		3.59M	2024-12
Biogen	USD 31.6M		700K	2025-09
BioMarin Pharmaceutical	USD 17.85M		973K	2025-09
Eli Lilly	USD 65M		25M	2025-09
Exelixis	USD 15.92M		867K	2025-09
Gilead Sciences	USD 88M		15M	2025-09
Incyte	USD 30.75M		3.97M	2025-12
Ionis Pharmaceuticals	USD -0.66		0.29	2024-12
MacroGenics	USD 1.53M		114K	2025-09
Merck	USD 96M		27M	2025-09
Moderna	USD 73M		8M	2025-09
Nektar Therapeutics	USD -0.18		0.07	2024-09
Pfizer	USD 0.62		156M	2025-09
Puma Biotechnology	USD 0.41		0.5	2024-09
Regeneron Pharmaceuticals	USD 175.1M		300K	2025-09
Sarepta Therapeutics	USD 8.38M		1.24M	2025-09
Ultragenyx Pharmaceutical	USD 5.86M		69K	2025-09
Vertex Pharmaceuticals	USD 125.7M		3.3M	2025-09